CELZ
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.Company Information
- Company Name
- CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
- CIK
- CIK0001187953
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- CELZ: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- CELZ
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-06-28
- Last sale
- 2025-02-19
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 750
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 372,588
- Shares outstanding
- 6,492,008
- Ownership
- 5.74%
Earnings Market Reaction
- Filing date
- 2026-08-07
- Price on filing date
- —
- 1-month reaction
- -19.72%
- 3-month reaction
- Pending
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | - | - | - | - | - | - | - | - | - | - | 3 | - | ||||||
| Cash And Cash Equivalents At Carrying Value | 9 | 6 | 7 | 5 | 7 | 8 | 6 | 6 | 7 | 9 | 3 | 5 | ||||||
| Certificates Of Deposit At Carrying Value | - | - | - | - | - | - | - | - | - | - | - | 7 | ||||||
| Inventory Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Investments | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 7 | - | ||||||
| Notes Receivable Net | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 9 | 6 | 7 | 5 | 7 | 8 | 6 | 6 | 8 | 9 | 10 | 12 | ||||||
Other Assets | ||||||||||||||||||
| Other Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finite Lived Intangible Assets Net | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | ||||||
| Assets | 9 | 6 | 8 | 6 | 7 | 8 | 7 | 7 | 8 | 10 | 11 | 13 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Accrued Liabilities Current | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities Current | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | - | 0 | 0 | 0 | - | 0 | - | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 82 | 78 | 78 | 74 | 74 | 74 | 71 | 70 | 70 | 70 | 70 | 70 | ||||||
| Retained Earnings Accumulated Deficit | -74 | -72 | -71 | -69 | -67 | -66 | -65 | -63 | -62 | -60 | -59 | -57 | ||||||
| Treasury Stock Common Value | -0 | -0 | -0 | -0 | -0 | -0 | 0 | -0 | -0 | -0 | -0 | - | ||||||
| Stockholders Equity | 9 | 6 | 8 | 6 | 7 | 8 | 6 | 7 | 8 | 9 | 10 | 12 | ||||||
| Treasury Stock Value | - | - | - | - | - | - | - | - | - | - | -0 | -0 | ||||||
| Minority Interest | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | ||||||
| Liabilities And Stockholders Equity | 9 | 6 | 8 | 6 | 7 | 8 | 7 | 7 | 8 | 10 | 11 | 13 | ||||||
| Common Stock No Par Value | - | - | - | - | - | - | - | - | - | - | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | ||||||
| Common Stock Shares Authorized | 25 | 25 | 25 | 25 | 25 | 25 | 5 | 5 | 5 | 5 | 5 | 5 | ||||||
| Preferred Stock Shares Outstanding | - | - | - | - | 0 | - | - | - | - | - | - | - | ||||||
| Common Stock Shares Issued | 6 | 4 | 4 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Shares Outstanding | 6 | 4 | 4 | 3 | 3 | 3 | 2 | 1 | 1 | 1 | 1 | 1 | ||||||
| Treasury Stock Common Shares | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | 0.00 | 0.00 | - | 0.00 | - | ||||||
| Preferred Stock Shares Authorized | 10 | 10 | 10 | 10 | 10 | - | 10 | 10 | 10 | - | 10 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialCREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) — SEC Financial Statements & Analysis
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) is a biological products, (no diagnostic substances) company, incorporated in NV. CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. trades on Nasdaq as: CELZ. CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07. Based on that filing, CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. carries a market cap of $9.42M, a P/E ratio of -1.56x, a P/B ratio of 1.09x, a P/S ratio of 3140.22x, an enterprise value of $706.55K, and an EV/EBITDA multiple of -0.12x. On profitability, it posts an operating margin of -208004.40%, a net margin of -201331.17%, a Return on Equity (ROE) of -77.90%, a Return on Assets (ROA) of -73.29%, and a Return on Invested Capital (ROIC) of -1547.04%. Per share, it reports EPS of $-0.93, diluted EPS of $-1.63, free cash flow per share of $-0.91, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -50.00% year-over-year, net income growth of 4.76% year-over-year, and EPS growth of -58.31% year-over-year. On the balance sheet, it maintains a current ratio of 12.91x, a quick ratio of 12.63x, working capital of $8.32M, a debt-to-equity ratio of 0.08x, a debt ratio of 0.07, an interest coverage ratio of -112402.64x, free cash flow of $-5.90M (TTM), and net debt of $-8.71M. Figures sourced from SEC EDGAR.
- Market Cap
- $9.42M
- P/E TTM
- -1.56x
- EPS TTM
- $-0.93
- P/B TTM
- 1.09x
- ROE TTM
- -77.90%
- ROA TTM
- -73.29%
- Debt To Equity
- 0.08x
- Free Cash Flow TTM
- $-5.90M
- Net Revenue TTM Growth 1Y
- -50.00%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. in?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does CELZ trade on?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) trades on the Nasdaq.
Where is CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. incorporated?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. is incorporated in NV.
When was CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)'s most recent SEC filing?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-07.
What is CELZ's market cap?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) has a market capitalization of $9.42M as of 2026-06-30.
What is CELZ's EPS (earnings per share)?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)'s trailing twelve month EPS is $-0.93 as of 2026-06-30.
What is CELZ's ROE (return on equity)?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)'s trailing twelve month Return on Equity (ROE) is -77.90% as of 2026-06-30.
What is CELZ's ROA (return on assets)?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)'s trailing twelve month Return on Assets (ROA) is -73.29% as of 2026-06-30.
What is CELZ's ROIC (return on invested capital)?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)'s trailing twelve month Return on Invested Capital (ROIC) is -1547.04% as of 2026-03-31.
What is CELZ's EV/EBITDA?
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)'s trailing twelve month EV/EBITDA is -0.12x as of 2026-06-30.